Your browser doesn't support javascript.
loading
Chagas disease is associated with a poor outcome at 1-year follow-up after cardiac resynchronization therapy.
Passos, Luiz Carlos Santana; Melo, Rodrigo Morel Vieira de; Lira, Yasmin Menezes; Oliveira, Natalia Ferreira Cardoso de; Trindade, Thiago; Carvalho, William; Fagundes, Alexsandro.
Afiliação
  • Passos LCS; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Melo RMV; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Lira YM; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Oliveira NFC; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Trindade T; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Carvalho W; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
  • Fagundes A; Hospital Ana Nery, Universidade Federal da Bahia, Salvador, BA, Brasil.
Rev Assoc Med Bras (1992) ; 65(11): 1391-1396, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31800902
BACKGROUND: Cardiac resynchronization therapy (CRT) is a therapeutic modality for patients with heart failure (HF). The effectiveness of this treatment for event reduction is based on clinical trials where the population of patients with Chagas' disease (DC) is underrepresented. OBJECTIVE: To evaluate the prognosis after CRT of a population in which CD is an endemic cause of HF. METHODS: A retrospective cohort conducted between January 2015 and December 2016 that included patients with HF and left ventricular ejection fraction (LVEF) of less than 35% and undergoing CRT. Clinical and demographic data were collected to search for predictors for the combined outcome of death or hospitalization for HF at one year after CRT implantation. RESULTS: Fifty-four patients were evaluated, and 13 (24.1%) presented CD as the etiology of HF. The mean LVEF was 26.2± 6.1%, and 36 (66.7%) patients presented functional class III or IV HF. After the mean follow-up of 15 (±6,9) months, 17 (32.1%) patients presented the combined outcome. In the univariate analysis, CD was associated with the combined event when compared to other etiologies of HF, 8 (47%) vs. 9 (13,5%), RR: 3,91 CI: 1,46-10,45, p=0,007, as well as lower values of LVEF. In the multivariate analysis, CD and LVEF remained independent risk factors for the combined outcome. CONCLUSION: In a population of HF patients undergoing CRT, CD was independently associated with mortality and hospitalization for HF.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Chagásica / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Chagásica / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil